ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 890

$713K Total Retail Price of All Prescriptions

Rank: 136 out of 890

1,067 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,067 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

8% of this provider’s 1,067 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 13,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCHLOROTHIAZIDE 763 658 1 9
AMLODIPINE BESYLATE 749 625 2 1
LISINOPRIL 687 585 3 4
METFORMIN HCL 668 556 4 6
LEVOTHYROXINE SODIUM 482 414 5 2
PRAVASTATIN SODIUM 448 305 6 10
SIMVASTATIN 423 352 7 5
LOVASTATIN 420 394 8 46
FUROSEMIDE 366 291 9 7
ATENOLOL 347 319 10 23
OMEPRAZOLE 341 302 11 8
METOPROLOL TARTRATE 339 297 12 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 324 232 13 21
HYDROCODONE-ACETAMINOPHEN 310 173 S3 14 3
METOPROLOL SUCCINATE 273 243 15 17
ATORVASTATIN CALCIUM 266 225 16 13
TAMSULOSIN HCL 261 230 17 32
LOSARTAN-HYDROCHLOROTHIAZIDE 249 213 18 57
ALENDRONATE SODIUM 212 203 19 38
LOSARTAN POTASSIUM 210 186 20 29
ZOLPIDEM TARTRATE 202 147 21 19
NEXIUM 195 160 22 14
CITALOPRAM HBR 189 160 23 20
SERTRALINE HCL 184 152 24 26
WARFARIN SODIUM 180 158 25 24
ALLOPURINOL 173 159 26 31
GLIPIZIDE ER 168 149 27 110
BENAZEPRIL HCL 162 140 28 44
GLIPIZIDE 161 151 29 62
GABAPENTIN 154 120 30 12
MELOXICAM 147 95 31 18
VERAPAMIL ER 137 121 32 87
POTASSIUM CHLORIDE 132 109 33 11
CRESTOR 131 94 34 25
CARVEDILOL 127 101 35 22
PANTOPRAZOLE SODIUM 116 79 36 34
DOXAZOSIN MESYLATE 109 97 37 70
TRAMADOL HCL 107 82 38 16
CLOPIDOGREL 97 92 39 28
RANITIDINE HCL 88 74 40 49
FLUTICASONE PROPIONATE 88 70 40 39
PROAIR HFA 88 68 40 55
AMITRIPTYLINE HCL 88 64 R 40 43
GLYBURIDE 86 80 R 44 83
FINASTERIDE 77 64 45 108
LANTUS 75 49 46 50
DIOVAN HCT 74 72 47 48
PLAVIX 73 71 48 42
SYNTHROID 72 69 49 53
BENAZEPRIL-HYDROCHLOROTHIAZIDE 68 62 50 179
OXYCODONE-ACETAMINOPHEN 67 45 S2 51 250
FENOFIBRATE 64 53 52 74
DIOVAN 62 62 53 33
CARBIDOPA-LEVODOPA 61 53 54 136
INSULIN SYRINGE 60 45 55 99
LIPITOR 60 60 55 77
ESCITALOPRAM OXALATE 59 49 57 51
TRIAMCINOLONE ACETONIDE 59 50 57 160
TRAZODONE HCL 54 32 59 40
SPIRONOLACTONE 54 42 59 85
TRIAMTERENE-HCTZ 52 52 61 61
FLUOXETINE HCL 52 39 61 63
DILTIAZEM ER 51 46 63 129
GLIPIZIDE XL 51 43 63 128
ALPRAZOLAM 50 0 65 95
GEMFIBROZIL 50 41 65 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.